SofosbuvirVelpatasvirQualityChecker

Sofosbuvir Velpatasvir

antivirals API biologics dissolution essential medicines global market heavy metals impurities
Open selection

Sofosbuvir/Velpatasvir Quality Checker — Combination Drug (Ph. Eur., USP)

ℹ️ The utility checks assay, sofosbuvir degradation, velpatasvir impurities, dissolution profile.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! Sofosbuvir degradation ≤0.5%. Velpatasvir Impurity A ≤0.5%. Dissolution synchronicity!

Usage:
SofosbuvirVelpatasvirQualityChecker.exe → demo mode
SofosbuvirVelpatasvirQualityChecker.exe input.csv output.json → evaluate data

Input format:
BatchNumber,Sofosbuvir_Assay_Percent,Sofosbuvir_Degradation_Percent,Sofosbuvir_Isomer_Percent,Velpatasvir_Assay_Percent,Velpatasvir_Impurity_A_Percent,Velpatasvir_Oxidized_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Toluene_ppm,Residual_Solvent_Acetonitrile_ppm,Residual_Solvent_Methanol_ppm,Heavy_Metals_ppm,Sulfated_Ash_Percent,Sofosbuvir_Dissolution_30min_Percent,Velpatasvir_Dissolution_30min_Percent,Sofosbuvir_Dissolution_60min_Percent,Velpatasvir_Dissolution_60min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected

Example:
SOF-VEL-2026-001,99.5,0.2,0.15,99.0,0.25,0.1,0.8,1.5,150,90,400,5,0.1,0.0,0.0,0.0,0.0,0.0,0.0,20,5,0,0

— WHY IS THIS NEEDED?
Sofosbuvir/Velpatasvir — combination drug for Hepatitis C treatment:
• Sofosbuvir (Nucleotide): Sensitive to hydrolysis forming inactive acid. Control of degradation is critical (≤0.5%).
• Velpatasvir (NS5A Inhibitor): Has complex structure and low solubility. Specific Impurity A and oxidized forms require strict control (≤0.5%).
• Synthesis often involves toluene and acetonitrile (ICH Q3C Class 2). Limits are strict.
• Dissolution Profile: It is critical that both components release synchronously, despite different solubilities, to ensure the correct pharmacological effect.
⚠️ CRITICAL:
• Sofosbuvir Assay: 95–105%
• Sofosbuvir Degradation: ≤ 0.5% (Critical!)
• Sofosbuvir Isomer: ≤ 0.5%
• Velpatasvir Assay: 95–105%
• Velpatasvir Impurity A: ≤ 0.5%
• Velpatasvir Oxidized Impurities: ≤ 0.5%
• Total Impurities: ≤ 2.0%
• Toluene: ≤ 890 ppm
• Acetonitrile: ≤ 410 ppm
• Methanol: ≤ 3000 ppm
• Heavy Metals: ≤ 10 ppm
• Dissolution (both components): Sofosbuvir ≥ 80% in 30 min, Velpatasvir ≥ 75% in 30 min
• Microbiology: standard limits
⚠️ Note: Utility adapted for dissolution profile check for two components with different solubilities. If dissolution data absent (0), check skipped (for substance). For finished forms, deviation from dissolution profile of either component or desynchronization of release is a critical defect. Control of sofosbuvir hydrolysis is an absolute priority for efficacy.

input.csv

BatchNumber,Sofosbuvir_Assay_Percent,Sofosbuvir_Degradation_Percent,Sofosbuvir_Isomer_Percent,Velpatasvir_Assay_Percent,Velpatasvir_Impurity_A_Percent,Velpatasvir_Oxidized_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Toluene_ppm,Residual_Solvent_Acetonitrile_ppm,Residual_Solvent_Methanol_ppm,Heavy_Metals_ppm,Sulfated_Ash_Percent,Sofosbuvir_Dissolution_30min_Percent,Velpatasvir_Dissolution_30min_Percent,Sofosbuvir_Dissolution_60min_Percent,Velpatasvir_Dissolution_60min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
SOF-VEL-2026-001,99.5,0.2,0.15,99.0,0.25,0.1,0.8,1.5,150,90,400,5,0.1,0.0,0.0,0.0,0.0,0.0,0.0,20,5,0,0

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: SofosbuvirVelpatasvirQualityCheckerAPI / object: Sofosbuvir VelpatasvirCategory: Global API expansion

1. Scope

The Sofosbuvir Velpatasvir Quality Checker utility is used for Sofosbuvir Velpatasvir. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Global API expansion

Tags: antivirals, API, biologics, dissolution, essential medicines, global market, heavy metals, impurities, microbiology, oncology

2. Execution modes

SofosbuvirVelpatasvirQualityChecker.exe                            → demo mode
SofosbuvirVelpatasvirQualityChecker.exe input.csv output.json      → evaluate data

3. Key controlled areas

  • assay / content
  • purity and impurities
  • dissolution / disintegration
  • residual solvents
  • microbiology and pathogens
  • heavy metals / elemental impurities

4. Domain limits and critical parameters

  • ⚠️ CRITICAL! Sofosbuvir degradation ≤0.5%. Velpatasvir Impurity A ≤0.5%. Dissolution synchronicity!
  • Sofosbuvir (Nucleotide): Sensitive to hydrolysis forming inactive acid. Control of degradation is critical (≤0.5%).
  • Velpatasvir (NS5A Inhibitor): Has complex structure and low solubility. Specific Impurity A and oxidized forms require strict control (≤0.5%).
  • ⚠️ CRITICAL:
  • Sofosbuvir Assay: 95–105%
  • Sofosbuvir Degradation: ≤ 0.5% (Critical!)
  • Sofosbuvir Isomer: ≤ 0.5%
  • Velpatasvir Assay: 95–105%
  • Velpatasvir Impurity A: ≤ 0.5%
  • Velpatasvir Oxidized Impurities: ≤ 0.5%
  • Total Impurities: ≤ 2.0%
  • Toluene: ≤ 890 ppm
  • Acetonitrile: ≤ 410 ppm
  • Methanol: ≤ 3000 ppm
  • Heavy Metals: ≤ 10 ppm
  • Dissolution (both components): Sofosbuvir ≥ 80% in 30 min, Velpatasvir ≥ 75% in 30 min
  • Microbiology: standard limits
  • ⚠️ Note: Utility adapted for dissolution profile check for two components with different solubilities. If dissolution data absent (0), check skipped (for substance). For finished forms, deviation from dissolution profile of either component or desynchronization of release is a critical defect. Control of sofosbuvir hydrolysis is an absolute priority for efficacy.
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Sofosbuvir Velpatasvir with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: assay / content, purity and impurities, dissolution / disintegration, residual solvents, microbiology and pathogens, heavy metals / elemental impurities.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberSOF-VEL-2026-001mandatory field; used for batch/lot traceability
2Sofosbuvir_Assay_Percentdecimal%Sofosbuvir Assay %99.5numeric value; compared with assay/purity limit from specification or method
3Sofosbuvir_Degradation_Percentdecimal%Sofosbuvir Degradation %0.2numeric value; compared with individual or total impurity limit
4Sofosbuvir_Isomer_Percentdecimal%Sofosbuvir Isomer %0.15mandatory numeric value; rule comparison is performed by the utility
5Velpatasvir_Assay_Percentdecimal%Velpatasvir Assay %99.0numeric value; compared with assay/purity limit from specification or method
6Velpatasvir_Impurity_A_Percentdecimal%Velpatasvir Impurity A %0.25numeric value; compared with individual or total impurity limit
7Velpatasvir_Oxidized_Percentdecimal%Velpatasvir Oxidized %0.1mandatory numeric value; rule comparison is performed by the utility
8Total_Impurities_Percentdecimal%Total Impurities %0.8mandatory numeric value; rule comparison is performed by the utility
9Loss_On_Drying_Percentdecimal%Loss On Drying %1.5mandatory numeric value; rule comparison is performed by the utility
10Residual_Solvent_Toluene_ppmdecimalppmResidual Solvent Toluene ppm150numeric value; checked as residual solvent against the applicable limit
11Residual_Solvent_Acetonitrile_ppmdecimalppmResidual Solvent Acetonitrile ppm90numeric value; checked as residual solvent against the applicable limit
12Residual_Solvent_Methanol_ppmdecimalppmResidual Solvent Methanol ppm400numeric value; checked as residual solvent against the applicable limit
13Heavy_Metals_ppmdecimalppmHeavy Metals ppm5numeric value; checked as elemental/metal impurity
14Sulfated_Ash_Percentdecimal%Sulfated Ash %0.1mandatory numeric value; rule comparison is performed by the utility
15Sofosbuvir_Dissolution_30min_Percentdecimal%Sofosbuvir Dissolution 30min %0.0numeric value; dissolution/disintegration profile checked according to method
16Velpatasvir_Dissolution_30min_Percentdecimal%Velpatasvir Dissolution 30min %0.0numeric value; dissolution/disintegration profile checked according to method
17Sofosbuvir_Dissolution_60min_Percentdecimal%Sofosbuvir Dissolution 60min %0.0numeric value; dissolution/disintegration profile checked according to method
18Velpatasvir_Dissolution_60min_Percentdecimal%Velpatasvir Dissolution 60min %0.0numeric value; dissolution/disintegration profile checked according to method
19Weight_Variation_RSDdecimalas specifiedWeight Variation RSD0.0mandatory numeric value; rule comparison is performed by the utility
20Friability_Percentdecimal%Friability %0.0mandatory numeric value; rule comparison is performed by the utility
21Microbial_Count_TAMCdecimalas specifiedMicrobial Count TAMC20numeric value; compared with microbiological limits
22Microbial_Count_TYMCdecimalas specifiedMicrobial Count TYMC5numeric value; compared with microbiological limits
23EColi_Detectedboolean / flag0/1EColi Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
24Salmonella_Detectedboolean / flag0/1Salmonella Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent

CSV example

BatchNumber,Sofosbuvir_Assay_Percent,Sofosbuvir_Degradation_Percent,Sofosbuvir_Isomer_Percent,Velpatasvir_Assay_Percent,Velpatasvir_Impurity_A_Percent,Velpatasvir_Oxidized_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Toluene_ppm,Residual_Solvent_Acetonitrile_ppm,Residual_Solvent_Methanol_ppm,Heavy_Metals_ppm,Sulfated_Ash_Percent,Sofosbuvir_Dissolution_30min_Percent,Velpatasvir_Dissolution_30min_Percent,Sofosbuvir_Dissolution_60min_Percent,Velpatasvir_Dissolution_60min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
SOF-VEL-2026-001,99.5,0.2,0.15,99.0,0.25,0.1,0.8,1.5,150,90,400,5,0.1,0.0,0.0,0.0,0.0,0.0,0.0,20,5,0,0

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable SofosbuvirVelpatasvirQualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Sofosbuvir Velpatasvir, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "SofosbuvirVelpatasvirQualityChecker",
  "api": "Sofosbuvir Velpatasvir",
  "batchNumber": "SOF-VEL-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "SOF-VEL-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Sofosbuvir_Assay_Percent",
      "value": "99.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Sofosbuvir_Degradation_Percent",
      "value": "0.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Sofosbuvir_Isomer_Percent",
      "value": "0.15",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Velpatasvir_Assay_Percent",
      "value": "99.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Velpatasvir_Impurity_A_Percent",
      "value": "0.25",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Velpatasvir_Oxidized_Percent",
      "value": "0.1",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Total_Impurities_Percent",
      "value": "0.8",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005Positive pathogen/microbiological flag or microbiological limit excursionCritical FAIL is produced with the offending parameter.
TC-006Insufficient dissolution or excessive disintegration timeFAIL/WARNING is produced according to method criticality.
TC-007Residual solvent above applicable limitFAIL is produced with solvent name and measured value.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Algeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Argentina: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Australia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Brazil: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Canada: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

China: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Colombia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Egypt: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

France: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Germany: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Infectious Diseases QC Suite

QC utility package for infectious diseases: antibacterial, antiviral, antifungal and antiparasitic products, microbiology, sterility, endotoxins, viral safety and vaccine release checks.

Open

Iran: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Italy: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Japan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Mexico: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Philippines: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Russia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Saudi Arabia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Korea: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Thailand: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Turkey: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United Kingdom: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United States: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Vietnam: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

World API Extension QC Suite

Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.

Open